Chlamydia-trachomatis-Infektionen - Zeit zum Handeln?

Zusammenfassung

Die urogenitale Infektion mit Chlamydia (C.) trachomatis ist die häufigste sexuell übertragbare Erkrankung der Welt. Bei Frauen finden sich C.-trachomatis-Infektionen gehäuft bis zum 25., bei Männern bis zum 35. Lebensjahr. In westeuropäischen Ländern bewegte sich die Prävalenz in den 90er Jahren laut Angaben der WHO zwischen 2,7 % (Italien) und 8 % (Island). Zur Zeit wird ein generelles Screening auf C. trachomatis in Deutschland diskutiert.

Die nicht erkannte und nicht behandelte C.-trachomatis-Infektion und die daraus resultierenden vielfachen und oft schwerwiegenden gesundheitlichen Störungen haben für die Betroffenen erhebliche individuelle körperliche, somatische und psychische Konsequenzen. Sie stellen für die Gesellschaft epidemiologisch und gesundheitsökonomisch ein erhebliches Problem dar, welches in einer Zeit des Geburtenrückgangs und der demografischen Wandlung auch von hoher familienpolitischer Bedeutung ist.

Summary

Infection with Chlamydia trachomatis is the most common sexually transmitted disease in the world. In women it mainly occurs before the age of 25 years, while in men it can still be diagnosed till the age of 35 years. In Western Europe the prevalence of a Chlamydia trachomatis infection has been estimated, according to WHO data, as between 2.7% (Italy) and 8.0% (Island). A general screening strategy is now being discussed in Germany. A non-diagnosed and non-treated Chlamydia trachomatis infection and the resulting health problems have not only severe consequences for the individual but also results in major epidemiological and socio-economic public health problems. This issue is not only of extreme importance in health policy, but has also a major impact in family policy, especially in view of the declining birth rates and the demographic changes.

Chlamydia trachomatis - Prävalenz - Diagnose - Therapie - Screening

Chlamydia trachomatis - prevalnece - diagnosis - treatment - screening

Literatur

• 1 Boyer C B, Shafer M A. et al . Sexually transmitted diseases in a health maintenance organization teen clinic: associations of race, partner’s age, and marijuana use.  Arch Pediatr Adolesc Med. 1999;  153 838-844
• 2 Cates W. Chlamydial infections and the risk of ectopic pregnancy.  Jama. 1999;  281 117-118
• 3 Cates W, Wasserheit J N. Genital chlamydial infections: epidemiology and reproductive sequelae.  Am J Obstet Gynecol. 1991;  164 1771-1781
• 4 Chokephaibulkit K, Patamasucon P, List M, Moore B, Rodriguez H. Genital Chlamydia trachomatis infection in pregnant adolescents in east Tennessee.  J Pediatr Adolesc Gynecol. 1997;  10 95-100
• 5 Clad A, Prillwitz J, Hintz K C. et al . Discordant prevalence of chlamydia trachomatis in asymptomatic couples screened using urine ligase chain reaction.  Eur J Clin Microbiol Infect Dis. 2001;  20 324-328
• 6 Cohen D A, Nsuami M, Martin D H, Farley T A. Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents.  Pediatrics. 1999;  104 1281-1285
• 7 Cohen I, Veille J C, Calkins B M. Improved pregnancy outcome following successful treatment of chlamydial infection.  Jama. 1990;  263 3160-3163
• 8 Currie M J, McNiven M, Yee T, Schiemer U, Bowden F J. Pooling of clinical specimens prior to testing for Chlamydia trachomatis by PCR is accurate and cost saving.  J Clin Microbiol. 2004;  42 4866-4867
• 9 Eggert-Kruse W, Rohr G, Kunt B. et al . Prevalence of Chlamydia trachomatis in subfertile couples.  Fertil Steril. 2003;  80 660-663
• 10 Friese K, Schäfer A, Hof H. Infektionen in der Gynäkologie und Geburtshilfe. Berlin Heidelberg New York Tokio, Springer 2002
• 11 Friese K, Schröder G, Beichert M, Melchert F. Determination of the prevalence of Chlamydia trachomatis in women in the area of Mannheim, Germany, by using the Abbott Testpack Chlamydia rapid enzyme immunoassay.  Klinisches Labor. 1994;  40 637-640
• 12 Gaydos C A, Howell M R, Pare B. et al . Chlamydia trachomatis infections in female military recruits.  N Engl J Med. 1998;  339 739-744
• 13 Genc M, Mardh A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women.  Ann Intern Med. 1996;  124 1-7
• 14 Gilles G, Klapp C, Diedrich K, Schaefer A. Chlamydien - eine heimliche Epidemie unter Jugendlichen.  Dtsch Arztebl. 2005;  102 A2021-A2025
• 15 Ginocchio R H, Veenstra D L, Connell F A, Marrazzo J M. The clinical and economic consequences of screening young men for genital chlamydial infection.  Sex Transm Dis. 2003;  30 99-106
• 16 Goeree R, Jang D, Blackhouse G. et al . Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario.  Sex Transm Dis. 2001;  28 701-709
• 17 Honey E, Augood C, Templeton A. et al . Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies.  Sex Transm Infect. 2002;  78 406-412
• 18 Honey E, Templeton A. Prevention of pelvic inflammatory disease by the control of C. trachomatis infection.  Int J Gynaecol Obstet. 2002;  78 257-261
• 19 Howell M R, Gaydos J C, McKee K T, Quinn T C, Gaydos C A. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.  Sex Transm Dis. 1999;  26 519-526
• 20 Howell M R, Quinn T C, Brathwaite W, Gaydos C A. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.  Sex Transm Dis. 1998;  25 108-117
• 21 Howell M R, Quinn T C, Gaydos C A. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.  Ann Intern Med. 1998;  128 277-284
• 22 Hu D, Hook E W, Goldie S J. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.  Ann Intern Med. 2004;  141 501-513
• 23 Kent C K, Branzuela A, Fischer L, Bascom T, Klausner J D. Chlamydia and gonorrhea screening in San Francisco high schools.  Sex Transm Dis. 2002;  29 373-375
• 24 Koch J, Kirschner W, Schäfer A. Bestimmung der Praevalenz genitaler HPV- und Chlamydia-trachomatis-Infektionen in einem repraesentativen Querschnitt der weiblichen Normalbevoelkerung in Berlin. Infektionsepidemiologische Forschung 1997
• 25 La Montagne D S, Patrick L E, Fine D N, Marrazzo J M. Re-evaluating selective screening criteria for Chlamydial infection among women in the U S Pacific Northwest.  Sex Transm Dis. 2004;  31 283-289
• 26 Mangione-Smith R, O’Leary J, McGlynn E A. Health and cost-benefits of chlamydia screening in young women.  Sex Transm Dis. 1999;  26 309-316
• 27 Marrazzo J M, Celum C L, Hillis S D. et al . Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy.  Sex Transm Dis. 1997;  24 131-141
• 28 Marrazzo J M, Fine D, Celum C L, DeLisle S, Handsfield H H. Selective screening for chlamydial infection in women: a comparison of three sets of criteria.  Fam Plann Perspect. 1997;  29 158-162
• 29 Martius J, Krohn M A, Hillier S L. et al . Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth.  Obstet Gynecol. 1988;  71 89-95
• 30 McGregor J A, French J I. Chlamydia trachomatis infection during pregnancy.  Am J Obstet Gynecol. 1991;  164 1782-1789
• 31 Miller W C, Ford C A, Morris M. et al . Prevalence of chlamydial and gonococcal infections among young adults in the United States.  Jama. 2004;  291 2229-2236
• 32 Miller W C, Hoffman I F, O’Owen-Dowd J. et al . Selective screening for chlamydial infection: which criteria to use?.  Am J Prev Med. 2000;  18 115-122
• 33 Nelson H D, Helfand M. Screening for chlamydial infection.  Am J Prev Med. 2001;  20 95-107
• 34 Nsuami M, Elie M, Brooks B N. et al . Screening for sexually transmitted diseases during preparticipation sports examination of high school adolescents.  J Adolesc Health. 2003;  32 336-339
• 35 Nyari T, Deak J, Nagy E. et al . Epidemiological study of Chlamydia trachomatis infection in pregnant women in Hungary.  Sex Transm Infect. 1998;  74 213-215
• 36 Nyari T, Nyari C, Woodward M. et al . Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis.  Acta Obstet Gynecol Scand. 2001;  80 300-306
• 37 Oakeshott P, Kerry S, Hay S, Hay P. Opportunistic screening for chlamydial infection at time of cervical smear testing in general practice: prevalence study.  Bmj. 1998;  316 351-352
• 38 Oh M K, Richey C M, Pate M S, Brown P R, Hook E W. High prevalence of Chlamydia trachomatis infections in adolescent females not having pelvic examinations: utility of PCR-based urine screening in urban adolescent clinic setting.  J Adolesc Health. 1997;  21 80-86
• 39 Paavonen J, Puolakkainen M, Paukku M, Sintonen H. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program.  Obstet Gynecol. 1998;  92 292-298
• 40 Rietmeijer C A, Bull S S, Ortiz C G, Leroux T, Douglas J M. Patterns of general health care and STD services use among high-risk youth in Denver participating in community-based urine chlamydia screening.  Sex Transm Dis. 1998;  25 457-463
• 41 Rimbach S, Wallwiener D, Baier S. et al . Chlamydia trachomatis: screening within the scope of prenatal care and rapid diagnosis in threatened premature labor.  Zentralbl Gynakol. 1993;  115 478-482
• 42 Robert Koch-Institut .Gonorrhö und genitale Chlamydiose in Deutschland nach Daten des STD-Sentinels des RKI. Epidemiologisches Bulletin 2004: 39
• 43 Ryan G M, Abdella T N, McNeeley S G, Baselski V S, Drummond D E. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome.  Am J Obstet Gynecol. 1990;  162 34-39
• 44 Schachter J, Grossman M, Sweet R L. et al . Prospective study of perinatal transmission of Chlamydia trachomatis.  Jama. 1986;  255 3374-3377
• 45 Stamm W E, Hicks C B, Martin D H. et al . Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study.  Jama. 1995;  274 545-549
• 46 Stergachis A, Scholes D, Heidrich F E. et al . Selective screening for Chlamydia trachomatis infection in a primary care population of women.  Am J Epidemiol. 1993;  138 143-153
• 47 Stock C, Guillen-Grima F, Prufer-Kramer L. et al . Sexual behavior and the prevalence of Chlamydia trachomatis infection in asymptomatic students in Germany and Spain.  Eur J Epidemiol. 2001;  17 385-390
• 48 van Valkengoed I G, Postma M J, Morre S A. et al . Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.  Sex Transm Infect. 2001;  77 276-282
• 49 Welte R, Kretzschmar M, Leidl R. et al . Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach.  Sex Transm Dis. 2000;  27 518-529
• 50 Westrom L, Wolner-Hanssen P. Pathogenesis of pelvic inflammatory disease.  Genitourin Med. 1993;  69 9-17